Network origin in Ji Li first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 | |
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ji Li via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| EVEREST MEDICINES LIMITED | Pharmaceuticals: Major | Director/Board Member Chairman | |
| The University of Chicago | College/University | Doctorate Degree Masters Business Admin | |
BeiGene Pharmaceuticals (Guangzhou) Co. Ltd.
 BeiGene Pharmaceuticals (Guangzhou) Co. Ltd. Pharmaceuticals: MajorHealth Technology BeiGene Pharmaceuticals (Guangzhou) Co., Ltd. engages in the manufacture of pharmaceutical products. The company was founded on April 14, 1999 and is headquartered in Guangzhou, China. | Pharmaceuticals: Major | Director/Board Member Chairman | |
BeiGene (Guangzhou) Co., Ltd.
 BeiGene (Guangzhou) Co., Ltd. Financial ConglomeratesFinance BeiGene (Guangzhou) Co., Ltd. engages in the research and development of biotechnology and pharmaceutical products. The company was founded on July 11, 2017 and is headquartered in Guangzhou, China. | Financial Conglomerates | Director/Board Member Chairman | |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd. | Investment Managers | Private Equity Investor Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree | |
| The Pennsylvania State University | College/University | Graduate Degree Undergraduate Degree | |
| I-MAB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Sales & Marketing | |
CITIC PE Funds Management Ltd.
 CITIC PE Funds Management Ltd. Investment ManagersFinance Part of CITIC PE (Hong Kong) Ltd., CITIC PE Funds Management Ltd. provides investment advice. The company is based in George Town, Cayman Islands. | Investment Managers | Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| Southeast University | College/University | Undergraduate Degree | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
| YUM! BRANDS, INC. | Restaurants | Chairman | |
| ACOTEC SCIENTIFIC HOLDINGS LIMITED | Medical Specialties | Director/Board Member | |
| 3SBIO INC. | Biotechnology | Director/Board Member | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer | |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Director/Board Member | ||
| Beijing Panmao Investment Management Co. Ltd. | Investment Managers | Corporate Officer/Principal | |
| Spectrum Dynamics Medical Group Ltd. | Chairman | ||
| BLUE SAIL MEDICAL CO.,LTD. | Miscellaneous Manufacturing | Director/Board Member | |
| BIOSENSORS INTERNATIONAL GROUP LTD | Medical Specialties | Director/Board Member | |
| SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | Medical Specialties | Director/Board Member | |
| COVANCE INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
I-Mab Bio-tech (Tianjin) Co. Ltd.
 I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Biotechnology | Director/Board Member | |
| Hubei University of Science & Technology | College/University | Undergraduate Degree | |
| China Pharmaceutical Industry Research & Dev. Association | Director/Board Member | ||
| RDPAC | Director/Board Member | ||
| China National Association of Industry & Commerce | Corporate Officer/Principal | ||
Portola Capital Partners
 Portola Capital Partners Investment ManagersFinance Portola Capital Partners is a private equity firm founded in 1992. The firm is headquartered in Silicon Valley, California. | Investment Managers | Private Equity Investor | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
SK Holdings, Inc.
 SK Holdings, Inc. BroadcastingConsumer Services Part of Match Group, Inc., SK Holdings, Inc. is a company based in New York, NY. | Broadcasting | Corporate Officer/Principal | |
Korea Evaluation Institute of Industrial Technology
 Korea Evaluation Institute of Industrial Technology Miscellaneous Commercial ServicesCommercial Services Korea Evaluation Institute of Industrial Technology operates as a research institute to develop technology for domestic industries. The company is based in Daegu, South Korea. The South Korean company is ultimately controlled by the Government of South Korea. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| GENEXINE, INC. | Biotechnology | Chief Executive Officer | |
| Nanjing Medical University | College/University | Graduate Degree | |
InxMed Biotechnology Nanjing Co., Ltd.
 InxMed Biotechnology Nanjing Co., Ltd. BiotechnologyHealth Technology InxMed Biotechnology Nanjing Co., Ltd. is a clinical-stage biotech company established in 2018, dedicated to developing innovative therapies to overcome treatment resistance, especially anti PD-1/PD-L1 resistance. InxMed is based in Nanjing, China, and has teams located in Shanghai and Beijing, with hubs in San Francisco and Melbourne. The Chinese company's innovations are inspired by patients and driven by in-depth understanding of disease biology and pharmacology. InxMed has raised tens of millions of US dollars in series A round financing and has an integrated high-caliber research and clinical development team across China, the US, and Australia. The company has built a unique innovative pipeline through its own discovery research and development and collaborative research and development. The company was founded in 2018 by Fei Cao and Zai Qi Wang, with Zai Qi Wang serving as the CEO since then. | Biotechnology | Director/Board Member | |
| C-Bridge Capital Partners LLC | Corporate Officer/Principal | ||
| Weill Cornell Medical College | College/University | Doctorate Degree | |
PT Kalbe Genexine Biologics
 PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Biotechnology | Director/Board Member | |
| Shandong Medical University | College/University | Doctorate Degree | |
C-Bridge Capital LLC
 C-Bridge Capital LLC Investment ManagersFinance C-Bridge Capital LLC (C-Bridge Capital) is a venture capital subsidiary of CBC Group founded in 2019 by Fu Wei. The firm is headquartered in New York.. | Investment Managers | Private Equity Investor | |
| University of Bern | College/University | Doctorate Degree | |
Conquer Cancer Foundation of the American Society of Clinical
 Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| Chinese American Hematologist & Oncologist Network | Corporate Officer/Principal | ||
| Hult International Business School | College/University | Masters Business Admin |
Statistics
International
| United States | 21 |
| China | 19 |
| Cayman Islands | 4 |
| Singapore | 3 |
| Hong Kong | 3 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 15 |
| Finance | 9 |
| Commercial Services | 3 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 73 |
| Corporate Officer/Principal | 46 |
| Chief Tech/Sci/R&D Officer | 25 |
| Independent Dir/Board Member | 19 |
| Undergraduate Degree | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Yung Cheng Chen | 26 |
| Wei Fu | 21 |
| Thomas Malley | 17 |
| Michael Keyoung | 17 |
| Ke Tang | 13 |
| Howard Liang | 12 |
| Xiao Bin Wu | 12 |
| sam Su | 10 |
| Michael Goller | 9 |
| Ross Pettit | 9 |
| Amy Peterson | 8 |
| Jane Huang | 8 |
| Eric Hedrick | 7 |
| Todd Yancey | 6 |
| Jian Xin Yang | 5 |
- Stock Market
- Insiders
- Ji Li
- Company connections
